Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 32961-32962 [2014-13388]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 110 / Monday, June 9, 2014 / Notices
Leroy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–13346 Filed 6–6–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices (ACIP)
Atlanta, Georgia 30333, telephone 404/639–
8836; Email ACIP@CDC.GOV.
Meeting is webcast live via the World Wide
Web; for instructions and more information
on ACIP please visit the ACIP Web site:
https://www.cdc.gov/vaccines/acip/
index.html.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
ehiers on DSK2VPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting of the
aforementioned committee:
This notice is being published on less than
15 days prior to the meeting date because no
earlier notification of the meeting was
practicable.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–13389 Filed 6–6–14; 8:45 am]
BILLING CODE 4163–18–P
[FR Doc. 2014–13387 Filed 6–6–14; 8:45 am]
Times and Dates:
8:00 a.m.–6:00 p.m., June 25, 2014.
8:00 a.m.–1:30 p.m., June 26, 2014.
Place: Centers for Disease Control and
Prevention, Tom Harkin Global
Communications Center, 1600 Clifton Road
NE., Building 19, Kent ‘‘Oz’’ Nelson
Auditorium, Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available.
Purpose: The committee is charged with
advising the Director, CDC, on the
appropriate use of immunizing agents. In
addition, under 42 U.S.C. § 1396s, the
committee is mandated to establish and
periodically review and, as appropriate,
revise the list of vaccines for administration
to vaccine-eligible children through the
Vaccines for Children (VFC) program, along
with schedules regarding the appropriate
periodicity, dosage, and contraindications
applicable to the vaccines. Further, under
provisions of the Affordable Care Act, at
section 2713 of the Public Health Service
Act, immunization recommendations of the
ACIP that have been adopted by the Director
of the Centers for Disease Control and
Prevention must be covered by applicable
health plans.
Matters for Discussion: The agenda will
include discussions on: Yellow fever vaccine,
human papillomavirus vaccines, influenza,
pneumococcal conjugate vaccine, tetanus,
diphtheria, and acellular pertussis vaccine in
healthcare personnel, meningococcal
vaccines, child/adolescent immunization,
adult immunization, immunization safety,
measles, hepatitis vaccines and vaccine
supply. Recommendation votes are
scheduled for yellow fever vaccine and
influenza. Time will be available for public
comment.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Stephanie Thomas, National Center for
Immunization and Respiratory Diseases,
CDC, 1600 Clifton Road NE., MS–A27,
32961
VerDate Mar<15>2010
15:08 Jun 06, 2014
Jkt 232001
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Demonstration Projects on
Health Systems Change to Integrate
Tobacco Dependence Treatment into
Clinical Care and Assessment of Related
Outcomes, Special Interest Projects
(SIP)14–028; and Applied Research and
Development of Tools to Address Pointof-Sale Tobacco Marketing, SIP14–029,
Panel B, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 9:00 a.m.–6:00 p.m., June
18, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters for Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Demonstration Projects on
Health Systems Change to Integrate Tobacco
Dependence Treatment into Clinical Care and
Assessment of Related Outcomes, SIP14–028;
and Applied Research and Development of
Tools to Address Point-of-Sale Tobacco
Marketing, SIP14–029, Panel B, initial
review.’’
Contact Person for More Information: M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway NE.,
Mailstop F–80, Atlanta, Georgia 30341,
Telephone: (770) 488–3585, EEO6@cdc.gov.
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
The meeting announced below
concerns Global and Territorial Health
Research Network—Coordinating
Center, Special Interest Projects
(SIP)14–021; and Global and Territorial
Health Research Network—
Collaborating Centers, SIP14–022, Panel
C, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 9:00 a.m.–6:00 p.m., June
17, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters for Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Global and Territorial Health
Research Network—Coordinating Center,
SIP14–021; and Global and Territorial Health
Research Network—Collaborating Centers,
SIP14–022, Panel C, initial review.’’
Contact Person for More Information:
Diana Bartlett, M.P.H., M.P.P., Health
Scientist, CDC, 1600 Clifton Road NE.,
Mailstop D–72, Atlanta, Georgia 30333,
Telephone: (404) 639–4938, ZXD5@
CDC.GOV.
This notice is being published on less than
15 days prior to the meeting date because no
earlier notification of the meeting was
practicable.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
E:\FR\FM\09JNN1.SGM
09JNN1
32962
Federal Register / Vol. 79, No. 110 / Monday, June 9, 2014 / Notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–13388 Filed 6–6–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–1856 and CMS–
1893, CMS–10068 and CMS–265–11]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
any of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
DATES: Comments must be received by
August 8, 2014.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number (OCN). To be
assured consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
ehiers on DSK2VPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
15:08 Jun 06, 2014
Jkt 232001
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number __, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Web site address at
https://www.cms.hhs.gov/
PaperworkReductionActof1995.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
Reports Clearance Office at (410) 786–
1326.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–1856 and CMS–1893 Request for
Certification in the Medicare and/or
Medicaid Program to Provide
Outpatient Physical Therapy and/or
Speech Pathology Services, and
Outpatient Physical Therapy—Speech
Pathology Survey Report
CMS–10068 Medicare Ombudsman
Customer Service Feedback Survey
CMS–265–11 Independent Renal
Dialysis Facility Cost Report Form
Under the Paperwork Reduction Act
(PRA) (44 U.S.C. 3501–3520), Federal
agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires Federal agencies to publish a
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: (CMS–1856)
Request for Certification in the Medicare
and/or Medicaid Program to Provide
Outpatient Physical Therapy and/or
Speech Pathology Services, and (CMS–
1893) Outpatient Physical Therapy—
Speech Pathology Survey Report; Use:
Form CMS–1856 is used as an
application to be completed by
providers of outpatient physical therapy
and/or speech-language pathology
services requesting participation in the
Medicare and Medicaid programs. This
form initiates the process for obtaining
a decision as to whether the conditions
of participation are met as a provider of
outpatient physical therapy, speechlanguage pathology services, or both. It
is used by the State agencies to enter
new providers into the Automated
Survey Process Environment (ASPEN).
Form CMS–1893 is used by the State
survey agency to record data collected
during an on-site survey of a provider of
outpatient physical therapy and/or
speech-language pathology services, to
determine compliance with the
applicable conditions of participation,
and to report this information to the
Federal government. The form is
primarily a coding worksheet designed
to facilitate data reduction and retrieval
into the ASPEN system. The
information needed to make
certification decisions is available to us
only through the use of information
abstracted from the form.
Form Numbers: CMS–1856 and CMS–
1893 (OMB control number: 0938–
0065); Frequency: Annually,
occasionally; Affected Public: Private
sector—Business or other for-profit and
Not-for-profit institutions; Number of
Respondents: 700; Total Annual
Responses: 700; Total Annual Hours:
613. (For policy questions regarding this
collection contact James Cowher at 410–
786–1948.)
2. Type of Information Collection
Request: Reinstatement with change of a
previously approved collection; Title of
Information Collection: Medicare
Ombudsman Customer Service
Feedback Survey; Use: The Centers for
Medicare and Medicaid Services
stresses a continuing need for setting
E:\FR\FM\09JNN1.SGM
09JNN1
]]>Agencies
[Federal Register Volume 79, Number 110 (Monday, June 9, 2014)]
[Notices]
[Pages 32961-32962]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-13388]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Global and Territorial Health
Research Network--Coordinating Center, Special Interest Projects
(SIP)14-021; and Global and Territorial Health Research Network--
Collaborating Centers, SIP14-022, Panel C, initial review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time and Date: 9:00 a.m.-6:00 p.m., June 17, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in
response to ``Global and Territorial Health Research Network--
Coordinating Center, SIP14-021; and Global and Territorial Health
Research Network--Collaborating Centers, SIP14-022, Panel C, initial
review.''
Contact Person for More Information: Diana Bartlett, M.P.H.,
M.P.P., Health Scientist, CDC, 1600 Clifton Road NE., Mailstop D-72,
Atlanta, Georgia 30333, Telephone: (404) 639-4938, ZXD5@CDC.GOV.
This notice is being published on less than 15 days prior to the
meeting date because no earlier notification of the meeting was
practicable.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices
[[Page 32962]]
pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2014-13388 Filed 6-6-14; 8:45 am]
BILLING CODE 4163-18-P
